News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,073 Results
Type
Article (13613)
Company Profile (109)
Press Release (248351)
Section
Business (87962)
Career Advice (464)
Deals (15328)
Drug Delivery (64)
Drug Development (36541)
Employer Resources (49)
FDA (6262)
Job Trends (6187)
News (150059)
Policy (14012)
Tag
Academia (435)
Alliances (23137)
Alzheimer's disease (361)
Approvals (6268)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4348)
Biotechnology (44)
Breast cancer (60)
Cancer (399)
Career advice (406)
Cell therapy (56)
Clinical research (30551)
Collaboration (194)
Compensation (79)
COVID-19 (748)
C-suite (58)
Data (425)
Diabetes (59)
Diagnostics (1241)
Drug pricing (59)
Earnings (31582)
Employer resources (43)
Events (36895)
Executive appointments (217)
FDA (6486)
Funding (128)
Gene therapy (62)
GLP-1 (301)
Government (1270)
Healthcare (3530)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5832)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3413)
Lung cancer (55)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9564)
Metabolic disorders (185)
Neuroscience (471)
NextGen Class of 2024 (1580)
Non-profit (591)
Northern California (490)
Obesity (109)
Opinion (111)
Patents (63)
People (28551)
Pharmaceutical (67)
Phase I (7948)
Phase II (12923)
Phase III (11606)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3178)
Radiopharmaceuticals (116)
Rare diseases (105)
Real estate (2629)
Regulatory (9878)
Research institute (563)
Resumes & cover letters (55)
Southern California (488)
Startups (1625)
United States (4824)
Vaccines (114)
Weight loss (81)
Date
Last 7 days (222)
Last 30 days (809)
Last 365 days (12472)
2024 (12416)
2023 (14246)
2022 (19556)
2021 (20070)
2020 (19035)
2019 (14887)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15474)
2014 (12422)
2013 (10594)
2012 (11396)
2011 (11922)
2010 (10890)
Location
Africa (312)
Arizona (43)
Asia (19868)
Australia (2565)
California (1152)
Canada (670)
China (137)
Colorado (46)
Connecticut (47)
Europe (38913)
Florida (180)
Illinois (133)
Indiana (95)
Japan (51)
Kansas (51)
Maryland (171)
Massachusetts (986)
Minnesota (64)
New Jersey (494)
New York (321)
North Carolina (292)
Northern California (490)
Pennsylvania (312)
South America (498)
Southern California (488)
Texas (158)
Virginia (45)
Washington State (78)
262,073 Results for "terns pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia
December 3, 2024
·
11 min read
Biotech Bay
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN) today announced that members of senior management will be participating in a virtual fireside chat at UBS Obesity Therapeutics Day on Thursday, May 23, 2024 at 1:00 p.m. ET.
May 17, 2024
·
1 min read
Weight loss
Terns Shares Climb as Investigational GLP-1 Pill Spurs 5% Weight Loss After 28 Days
Terns Pharmaceuticals will advance TERN-601 into Phase II after early-stage data showed the oral therapy led to weight loss of 4.9%, comparable with weight loss pills Lilly and Pfizer are developing, according to analysts.
September 9, 2024
·
1 min read
·
Annalee Armstrong
Biotech Bay
Terns Pharmaceuticals to Participate in Upcoming June 2024 Investor Conferences
Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in June.
May 30, 2024
·
1 min read
Press Releases
Terns Pharmaceuticals to Participate in Upcoming November 2024 Investor Conferences
November 7, 2024
·
1 min read
Funding
Terns Announces $125M Raise on Heels of Oral GLP-1 Data Drop
Phase I data for TERN-601 suggests Terns’ oral GLP-1 candidate for obesity could be a contender in the market next to big names like Lilly, Pfizer and Roche.
September 10, 2024
·
1 min read
·
Kate Goodwin
Press Releases
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
November 19, 2024
·
5 min read
Biotech Bay
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN) today announced that members of senior management will be participating in a fireside chat at The Citizens JMP Life Sciences Conference 2024 on Tuesday, May 14, 2024 at 1:30 p.m. ET.
May 7, 2024
·
1 min read
Business
Terns Pharmaceuticals Announces Leadership Changes
Terns Pharmaceuticals, Inc. announced the appointment of Scott Harris as chief development officer effective May 28, 2024 and the upcoming departure of Erin Quirk, M.D., president, head of research and development.
May 8, 2024
·
6 min read
Biotech Bay
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for TERN-701 for the treatment of chronic myeloid leukemia (CML).
March 11, 2024
·
1 min read
1 of 26,208
Next
